Angiogenesis assays: An appraisal of current techniques

Angiogenesis Modulations in Health and Disease: Practical Applications of Pro- and Anti-angiogenesis Targets

Volumn , Issue , 2013, Pages 1-12

  Mousa, Shaker A ^a   Davis, Paul J ^a,b  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84931300629     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-6467-5_1     Document Type: Chapter

References (32)

1. Goodwin AM (2007) In vitro assays of angiogenesis for assessment of angiogenic and antiangiogenic agents. Microvasc Res 74(2-3):172-183
2. Ucuzian AA, Greisler HP (2007) In vitro models of angiogenesis. World J Surg 31(4):654-663
3. Staton CA, Reed MWR, Brown NJ (2009) A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Path 90:195-221
4. Jensen LD, Cao R, Cao Y (2009) In vivo angiogenesis and lymphangiogenesis models. Curr Mol Med 9(8):982-991
5. Loi M, Di Paolo D, Becherini P, Zorzoli A, Perri P, Carosio R, Cilli M, Ribatti D, Brignole C, Pagnan G, Ponzoni M, Pastorino F (2011) The use of the orthotopic model to validate antivascular therapies for cancer. Int J Dev Biol 55:547-555
6. Cimpean A-C, Ribatti D, Raica M (2011) A brief history of angiogenesis assays. Int J Dev Biol 55:377-382
7. Auerbach R, Kubai L, Knighton D, Folkman J (1974) A simple procedure for the long-term cultivation of chicken embryos. Dev Biol 41(2):391-394
8. Ribatti D, Conconi MT, Nussdorfer GG (2007) Nonclassic endogenous novel regulators of angiogenesis. Pharmacol Rev 59(2):185-205
9. Vargas A, Zeisser-Labouebe M, Lnge N, Gurny R, Delie F (2007) The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Rev 59(11):1162-1176
10. Mousa SS, Mousa SA (2005) Effect of resveratrol on angiogenesis and platelet/fibrinaccelerated tumor growth in the chick chorioallantoic membrane model. Nutr Cancer 52(1):59-65
11. Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Duskin E, Davis FB, Lin HY, Davis PJ (2008) Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Angiogenesis 11(2):183-190
12. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ (2005) Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864-2871
13. Davis PJ, Davis FB, Mousa SA (2009) Thyroid hormone-induced angiogenesis. Curr Cardiol Rev 5:12-16
14. Davis PJ, Davis FB, Mousa SA, Luidens MK, Lin HY (2011) Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. Annu Rev Pharmacol Toxicol 51:99-115
15. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ (1999) Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am J Physiol 276:C1014-C1024
16. Tobia C, De Sena G, Presta M (2011) Zebrafish embryo, a tool to study tumor angiogenesis. Int J Dev Biol 55(4-5):505-509
17. Talmadge JE, Donkor M, Scholar E (2007) Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 26(3-4):373-400
18. Langenkamp E, Molema G (2009) Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer. Cell Tissue Res 335(1):205-222
19. Yalcin M, Lin HY, Sudha T, Bharali DJ, Meng R, Tang HY, Davis FB, Stain SC, Davis PJ, Mousa SA (2013) Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles. Horm Cancer. doi: 10.1007/s12672-0137-y
20. Powell JA, Mohamed SN, Kerr JS, Mousa SA (2000) Antiangiogenesis efficacy of nitric oxide donors. J Cell Biochem 80(1):104-114
21. Nicosia RF, Otinetti A (1990) Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin and plasma clot. In Vitro Cell Dev Biol 26(2):119-128
22. Zhu WH, Nicosia RF (2002) The thin prep rat aortic ring assay: a modified method for the characterization of angiogenesis in whole mounts. Angiogenesis 5(1-2):81-86
23. Mousa SA, O'Connor L, Davis FB, Davis PJ (2006) Proangiogenesis action of the thyroid hormone analog 3, 5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology 147(4):1602-1607
24. Kubota Y, Kleinman HK, Martin GR, Lawley TJ (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillarylike structures. J Cell Biol 107(4):1589-1598
25. Arnaoutva I, George J, Kleinman HK, Benton G (2009) The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12(3):267-274
26. Donovan D, Brown NJ, Bishop ET, Lewis CE (2001) Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 4(2):113-121
27. Phillips PG, Birnby LM, Narendran A, Milonovich WL (2001) Nitric oxide modulates capillary formation at the endothelial cell-tumor cell interface. Am J Physiol 281:278-290
28. Phillips PG, Birnby L (2004) Nitric oxide modulates Caveolin-1 (Cav-1) and MMP-9 expression and distribution at the endothelial cell/tumor cell interface. Am J Physiol Lung Cell Mol Physiol 286:L1055-1065
29. Lincoln DW II, Phillips PG, Bove K (2003) Estrogen-induced Ets-1 promotes capillary formation in an in vitro tumor angiogenesis model. Breast Cancer Res Treat 78:167-178
30. Hetheridge C, Mavria G, Mellor H (2011) Uses of the in vigor endothelial-fibroblast organotypic co-culture assay in angiogenesis research. Biochem Soc Trans 39(6):1597-1600
31. Wessels JT, Busse AC, Mahrt J, Dulin C, Grabbe E, Mueller GA (2007) In vivo imaging in experimental preclinical tumor research-A review. Cytometry A 71(8):542-549
32. Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA (2000) Domain 5 of high molecular weight kininogen (kininostatin) downregulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood 95(2):543-560